Costly Drug for Fatal Muscular Disease Wins F.D.A. Approval

Spinraza, a “life-changing” drug for spinal muscular atrophy, will cost as much as $ 750,000 for the first year of treatment and $ 375,000 annually after that.
NYT > Business Day